Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share – Diluted of $0.54; 2023 Net Income per Share – Diluted of $0.54; and 4Q23 and 2023 FFO per Share – Diluted, As Adjusted, of $2.28 and $8.97, respectively

(PRNewsfoto/Alexandria Real Estate Equities, Inc.)

PASADENA, Calif., Jan. 29, 2024 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the fourth quarter and year ended December 31, 2023.

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)

Alexandria Real Estate Equities, Inc. All rights reserved. ©2024 (PRNewsfoto/Alexandria Real Estate Equities, Inc.)










Key highlights









Operating results

4Q23


4Q22


2023


2022


Total revenues:









In millions

$        757.2


$        670.3


$      2,885.7


$      2,589.0


Growth

13.0 %



11.5 %



Net (loss) income attributable to Alexandria’s common stockholders – diluted

In millions

$         (91.9)


$          51.8


$           92.4


$         513.3


Per share

$         (0.54)


$          0.31


$           0.54


$           3.18


Funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted


In millions

$        389.8


$        353.6


$      1,532.3


$      1,361.7


Per share

$          2.28


$          2.14


$           8.97


$           8.42


Celebrating 30 years at the vanguard and heart of the $5 trillion secularly growing life science industry

We celebrated the 30th anniversary of our one-of-a-kind, once-in-a-generation company on January 5, 2024. Alexandria pioneered the novel Labspace® niche and created the first-ever REIT uniquely focused on the critically important life science industry with our founding on January 5, 1994. Over the past three decades, we have transformed life science real estate from a specialty niche into a compelling mainstream asset class. From our IPO on May 27, 1997 through December 31, 2023, we generated an outstanding total shareholder return (“TSR”) of 1,512%, significantly outperforming major indices over the same period, including the FTSE Nareit Equity Health Care Index’s TSR of 980% and the MSCI US REIT Index’s TSR of 792% (assuming reinvestment of dividends).

An operationally excellent, industry-leading REIT with a high-quality, diverse client base to support growing revenues, stable cash flows, and strong margins

Percentage of total annual rental revenue in effect from mega campuses as of

    December 31, 2023


75 %



Percentage of total annual rental revenue in effect from investment-grade or

    publicly traded large cap tenants as of December 31, 2023


52 %



Sustained strength in tenant collections:





 Low tenant receivables as of December 31, 2023


$     8.2

million

 January 2024 tenant rents and receivables collected as of January 29, 2024


99.4 %



 4Q23 tenant rents and receivables collected as of January 29, 2024


99.9 %



Occupancy of operating properties in North America as of December 31, 2023


94.6 %



Operating margin


71 %



Adjusted EBITDA margin


69 %



Weighted-average remaining lease term as of December 31, 2023:





 Top 20 tenants


9.6

years

 All tenants


7.4

years

Solid annual leasing volume and rental rate increases with continued long lease terms

  • Solid leasing volume aggregating 889,737 RSF during 4Q23 and 4.3 million RSF for 2023.
  • Weighted-average lease term of 11.3 years for 2023, above our historically long weighted-average lease term of 8.8 years over the last 10 years.
  • 76% of our leasing activity during the last twelve months was generated from our existing tenant base.


4Q23



2023


Total leasing activity – RSF


889,737



4,306,072


Leasing of development and redevelopment space – RSF


233,516



596,533


Lease renewals and re-leasing of space:







RSF (included in total leasing activity above)


477,142



3,046,386


Rental rate increase


9.2 %

(1)


29.4 %

(1)

Rental rate increase (cash basis)


5.5 %

(1)


15.8 %

(1)



(1)

Includes the re-lease of 99,557 RSF to Cargo Therapeutics at 835 Industrial at a 4.1% decline in the cash rental rate compared with the rate from the former tenant that was less than three years into a 10-year lease. Excluding this lease, the rental rate increase on renewals and re-leasing of space was 21.4% and 9.7% (cash basis) for 4Q23 and 32.4% and 17.0% (cash basis) for 2023.

Strong and flexible balance sheet with significant liquidity, top 10% credit rating ranking among all publicly traded U.S. REITs

  • Net debt and preferred stock to Adjusted EBITDA of 5.1x, equaling the lowest leverage levels in Company history, and fixed-charge coverage ratio of 4.5x for 4Q23 annualized.
  • Significant liquidity of $5.8 billion.
  • No debt maturities prior to 2025.
  • Only 20% of our total debt matures in the next five years.
  • 12.8 years weighted-average remaining term of debt.
  • 98.1% of our debt has a fixed rate.
  • Total debt and preferred stock to gross assets of 27%.
  • $1.2 billion of expected capital contribution commitments from existing consolidated real estate joint venture partners to fund construction from 1Q24 through 2027.
  • During 4Q23, we settled our outstanding forward equity sales agreements by issuing 699 thousand shares of common stock, for which we received net proceeds of $104.3 million.

Alexandria’s highly leased value-creation pipeline delivered the highest incremental annual net operating income in Company history of $145 million and $265 million, commencing during 4Q23 and 2023, respectively, and drives future incremental annual net operating income aggregating $495 million

  • During 4Q23, we placed into service development and redevelopment projects aggregating 1.2 million RSF that are 99% leased across multiple submarkets and delivered incremental annual net operating income of $145 million. 4Q23 deliveries include:
    • Accelerated delivery of 462,100 RSF at 325 Binney Street in our Cambridge submarket, which is 100% leased to Moderna, Inc.;
    • 345,996 RSF at 15 Necco Street in our Seaport Innovation District submarket, which is 97% leased to Eli Lilly and Company;
    • 278,282 RSF at 1150 Eastlake Avenue East, a multi-tenant building, in our Lake Union submarket, which is 100% leased; and
    • 88,038 RSF at 6040 George Watts Hill Drive in our Research Triangle submarket, which is 100% leased to FUJIFILM Diosynth Biotechnologies.
  • Annual net operating income (cash basis) is expected to increase by $114 million upon the burn-off of initial free rent from recently delivered projects. Initial free rent has a weighted-average burn-off period of 10 months.
  • 66% of RSF in our value-creation pipeline is within our mega campuses.

(dollars in millions)


Incremental

Annual Net

Operating Income


RSF


Leased/

Negotiating

Percentage


Placed into service:








YTD 3Q23


$                    120


1,290,721


100 %


4Q23


145


1,228,604


99


Placed into service in 2023


$                    265


2,519,325


100 %










Expected to be placed into service(1):








2024


$                    149

(2)

5,697,062


60%(3)


2025


146




1Q26 through 4Q27


200






$                    495






(1)

Represents expected incremental annual net operating income to be placed into service, including partial deliveries for projects that stabilize in future years.

(2)

Includes 1.4 million RSF expected to be stabilized in 2024 and is 93% leased. Refer to the initial and stabilized occupancy years in the “New Class A/A+ development and redevelopment properties: current projects” of our Supplemental Information for additional information.

(3)

70% of the leased RSF of our value-creation projects was generated from our existing tenant base.

Continued solid net operating income and internal growth

  • Net operating income (cash basis) of $1.9 billion for 4Q23 annualized, up $190.4 million, or 11.3%, compared to 4Q22 annualized.
  • Same property net operating income growth:
    • 3.4% and 4.6% (cash basis) for 2023 over 2022, in line with our previously provided 2023 guidance.
    • 0.7% and 0.8% (cash basis) for 4Q23 over 4Q22, including four properties in our Greater Boston, San Francisco Bay Area, and San Diego markets, with temporary vacancy aggregating 331,454 RSF. This RSF is currently 64% leased/negotiating, with leases expected to commence primarily during 2H24.
  • 96% of our leases contain contractual annual rent escalations approximating 3%.

Consistent dividend strategy focuses on retaining significant net cash flows from operating activities after dividends for reinvestment

  • Common stock dividend declared for 4Q23 of $1.27 per common share, aggregating $4.96 per common share for the year ended December 31, 2023, up 24 cents, or 5%, over the year ended December 31, 2022.
  • Dividend yield of 4.0% as of December 31, 2023.
  • Dividend payout ratio of 56% for the three months ended December 31, 2023.
  • Average annual dividend per-share growth of 6% from 2019 to 2023.
  • Significant net cash flows from operating activities after dividends retained for reinvestment aggregating $1.9 million for the years ended December 31, 2019 through 2023.

Execution of our value harvesting and asset recycling 2023 self-funding strategy

Our 2023 capital plan included $1.4 billion in funding primarily from dispositions and partial interest sales, of which $439.0 million was completed during 4Q23, and focused on the enhancement of our asset base through the following:

(in millions)


Completed in 2023

Value harvesting dispositions of 100% interest in properties not integral to our

   mega campus strategy



$      1,042


Strategic dispositions and partial interest sales



273


Proceeds of forward equity sales agreements entered into during 2022 and

   settled in 4Q23



104


Total



$      1,419


In January 2024, our existing ATM program became inactive upon expiration of the associated shelf registration. We expect to file a new shelf registration and ATM program in the near future.

Strong balance sheet management

Key metrics as of or for December 31, 2023

  • $33.1 billion in total market capitalization.
  • $21.8 billion in total equity capitalization, which ranks in the top 10% among all publicly traded U.S. REITs.


4Q23


Target



Quarter

Annualized


Trailing

12 Months


4Q24

Annualized

Net debt and preferred stock to

   Adjusted EBITDA


5.1x


5.4x


Less than or equal to 5.1x

Fixed-charge coverage ratio


4.5x


4.7x


Greater than or equal to 4.5x

Investments

  • As of December 31, 2023:
    • Our non-real estate investments aggregated $1.4 billion.
    • Unrealized gains presented in our consolidated balance sheet were $196.9 million, comprising gross unrealized gains and losses aggregating $320.4 million and $123.5 million, respectively.
  • Investment income of $8.7 million for 4Q23 presented in our consolidated statement of operations consisted of $19.5 million of unrealized gains and $10.8 million of realized losses. Realized losses include $12.3 million of realized gains, offset by impairment charges of $23.1 million.

Other key highlights

Key items included in net income attributable to Alexandria’s common stockholders:










YTD


4Q23


4Q22


4Q23


4Q22


2023


2022


2023


2022

(in millions, except per share

   amounts)

Amount


Per Share –

Diluted


Amount


Per Share –

Diluted

Unrealized gains (losses) on

   non-real estate investments

$   19.5


$  (24.1)


$  0.11


$ (0.15)


$  (201.5)


$  (412.2)


$ (1.18)


$ (2.55)

Gain on sales of real estate

62.2



0.36



277.0


537.9


1.62


3.33

Impairment of non-real

   estate investments

(23.1)


(20.5)


(0.13)


(0.12)


(74.6)


(20.5)


(0.44)


(0.13)

Impairment of real estate

(271.9)

(1)

(26.2)


(1.59)


(0.16)


(461.1)


(65.0)


(2.70)


(0.40)

Loss on early extinguishment

   of debt






(3.3)



(0.02)

Acceleration of stock

   compensation expense due

   to executive officer

   resignations

(18.4)



(0.11)



(20.3)


(7.2)


(0.12)


(0.04)

  Total

$  (231.7)


$  (70.8)


$ (1.36)


$ (0.43)


$  (480.5)


$   29.7


$ (2.82)


$  0.19



(1)

Represents impairment charges to reduce our investments in real estate assets to their respective estimated fair values less costs to sell upon their classification as held for sale, primarily consisting of non-laboratory assets that are not integral to our mega campus strategy, including (i) $94.8 million for two non-laboratory properties in our Seaport Innovation District submarket, (ii) $93.5 million for an office property in our New York City submarket, (iii) $36.1 million for a development land parcel in our Seaport Innovation District submarket, and (iv) $29.7 million for an office property in our Bothell submarket. We initially acquired these real estate assets with the intention to entitle or reposition each site as part of a life science campus, including the demolition of properties as necessary, upon expiration of the existing in-place leases, and ultimately develop or redevelop life science properties. Since acquiring these assets, the macroeconomic environment has changed and we decided not to proceed with them.

Refer to “Funds from operations and funds from operations per share” of this Earnings Press Release for additional details.

Industry and corporate responsibility leadership: catalyzing and leading the way for positive change to benefit human health and society

  • In November 2023, Alexandria earned several 2023 TOBY (The Outstanding Building of the Year) Awards from BOMA (Building Owners and Managers Association) in Boston, San Diego, and Seattle King County:
    • In our Greater Boston market, 60 Binney Street on our Alexandria Center® at Kendall Square mega campus won in the Laboratory Building category, and Buildings 200 and 1400 on our Alexandria Center® at One Kendall Square mega campus won in the Historical Building and Renovated Building categories, respectively.
    • In our San Diego market, 9880 Campus Point Drive on our Campus Point by Alexandria mega campus, which is home to Alexandria GradLabs®, won a TOBY in the region’s first-ever Life Science category.
    • In our Seattle market, 1165 Eastlake Avenue East on The Eastlake Life Science Campus by Alexandria mega campus won a TOBY in the region’s first-ever Life Science category.
  • Alexandria continues to address some of today’s most pressing societal challenges through our impactful social responsibility pillars, with a prioritized focus on mental health and addiction. OneFifteen, a data-driven comprehensive care model for treating people living with addiction, which we pioneered in partnership with Verily, celebrated the fourth anniversary of its campus in Dayton, Ohio in October 2023. Since it opened its doors in 2019, OneFifteen has treated over 7,500 patients at this patient-centered holistic learning health system.

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

Guidance

December 31, 2023

(Dollars in millions, except per share amounts) 


The following guidance for 2024 has been updated to reflect our current view of existing market conditions and assumptions for the year ending December 31, 2024. There can be no assurance that actual results will not be materially higher or lower than these expectations. Also, refer to our discussion of “forward-looking statements” on page 7 of this Earnings Press Release for additional details. Key updates to our 2024 guidance from November 29, 2023 are summarized below which includes a $125 million reduction in excess 2023 bond capital held as cash at December 31, 2023 and a corresponding increase in incremental debt.







2024 Guidance Midpoint

Summary of Change in Key Credit Metric Targets


As of 1/29/24


As of 11/29/23


Summary of Key Changes in Sources and Uses of Capital


As of 1/29/24


As of 11/29/23

Fixed-charge coverage ratio – 4Q24 annualized


Greater than or

equal to 4.5x


4.5x to 5.0x


Incremental debt


$900


$775




Excess 2023 bond capital held as cash at December 31, 2023


$—


$125












Key Credit Metric Targets(1)




Net debt and preferred stock to Adjusted EBITDA – 4Q24 annualized


Less than or equal to 5.1x


Fixed-charge coverage ratio – 4Q24 annualized


Greater than or equal to 4.5x






Projected 2024 Earnings per Share and Funds From Operations per Share Attributable to

   Alexandria’s Common Stockholders – Diluted


Earnings per share(2)


$3.49 to $3.69


Depreciation and amortization of real estate assets



5.95



Allocation to unvested restricted stock awards



(0.07)



Funds from operations per share(3)


$9.37 to $9.57


Midpoint


$9.47



Key Sources and Uses of Capital


Range


Midpoint


Sources of capital:








Incremental debt


$        900


$        900


$        900


Net cash provided by operating activities after dividends


400


500


450


Dispositions and sales of partial interests(4)(5)


900


1,900


1,400


Total sources of capital


$     2,200


$     3,300


$     2,750


Uses of capital:








Construction 


$     1,950


$     2,550


$     2,250


Acquisitions(6)


250


750


500


Total uses of capital


$     2,200


$     3,300


$     2,750


Incremental debt (included above):








Issuance of unsecured senior notes payable(7)


$        600


$     1,400


$     1,000


Unsecured senior line of credit, commercial paper, and other


300


(500)


(100)


Net incremental debt


$        900


$        900


$        900




Key Assumptions


Low


High


Occupancy percentage in North America as of December 31, 2024


94.6 %


95.6 %


Lease renewals and re-leasing of space:






Rental rate increases


11.0 %


19.0 %


Rental rate increases (cash basis)


5.0 %


13.0 %


Same property performance:






Net operating income increases


0.5 %


2.5 %


Net operating income increases (cash basis)


3.0 %


5.0 %


Straight-line rent revenue


$            169


$            184


General and administrative expenses


$            181


$            191


Capitalization of interest


$            325


$            355


Interest expense


$            154


$            184


Realized gains on non-real estate investments(8)


$              95


$            125




(1)

Refer to each metric’s corresponding definition within the “Definitions and reconciliations” of our Supplemental Information.

(2)

Excludes unrealized gains or losses on non-real estate investments after December 31, 2023 that are required to be recognized in earnings and are excluded from funds from operations per share, as adjusted.

(3)

Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in the “Definitions and reconciliations” of our Supplemental Information for additional information.

(4)

As of January 29, 2024, we have pending real estate dispositions subject to signed letters of intent or purchase and sale agreements aggregating $142.4 million.

(5)

In January 2024, our existing ATM program became inactive upon expiration of the associated shelf registration. We expect to file a new shelf registration and ATM program in the near future.

(6)

Primarily represents strategic acquisitions that expand existing mega campuses or are associated with a new mega campus. We have completed acquisitions aggregating $103.3 million as of January 29, 2024.

(7)

Our guidance assumes we issue new unsecured senior notes payable in 2025 to fund the repayment of our $600 million unsecured senior notes payable due on April 30, 2025. Subject to market conditions, we may seek opportunities in 2024 to fund the repayment of our 2025 debt maturity through the issuance of additional unsecured senior notes payable.

(8)

Represents realized gains and losses included in funds from operations per share – diluted, as adjusted, and excludes significant impairments realized on non-real estate investments, if any. Refer to “Investments” of our Supplemental Information for additional details.



Acquisitions

December 31, 2023

(Dollars in thousands) 


Property


Submarket/Market


Date of

Purchase


Number of

Properties


Operating

Occupancy


Square Footage


Purchase

Price

Acquisitions With Development/Redevelopment Opportunities(1)




Future

Development


Active

Development/

Redevelopment


Operating With Future

 Development/

Redevelopment


Total(2)


2023 Acquisitions




















Canada


Canada


1/30/23


1


100 %




247,743


247,743


$      100,837

Other


Various


Various


4


100


1,089,349


110,717


185,676


1,385,742


158,139

Total 2023 acquisitions






5


100 %


1,089,349


110,717


433,419


1,633,485


$      258,976





















2024 Acquisitions




















Completed through January 29, 2024


Various


Various



N/A


300,000




300,000


$      103,250

Pending acquisitions subject to signed

   letters of intent or purchase and

   sale agreements



















358,746




















$      461,996





















2024 guidance range

















$250,000 – $750,000





















(1)

We expect to provide total estimated costs and related yields for development and redevelopment projects in the future, subsequent to the commencement of construction.

(2)

Represents total square footage upon completion of development or redevelopment of one or more new Class A/A+ properties. Square footage presented includes RSF of buildings currently in operation with future development or redevelopment opportunities. Refer to “Investments in real estate” in the “Definitions and reconciliations” of our Supplemental Information for additional details on value-creation square feet currently included in rental properties.

 

Dispositions and Sales of Partial Interests

December 31, 2023

(Dollars in thousands, except per RSF amounts)

Property


Submarket/Market


Date of

Sale


Interest

 Sold


RSF


Capitalization

 Rate


Capitalization

Rate

(Cash Basis)


Sales Price


Sales Price

per RSF


Value harvesting dispositions of 100% interest in

    properties not integral to our mega campus strategy





















Completed in YTD 3Q23:





















11119 North Torrey Pines Road


Torrey Pines/San Diego


5/4/23


100 %



72,506


4.4 %



4.6 %



$         86,000


$        1,186


225, 266, and 275 Second Avenue and 780 and 790

   Memorial Drive(1)


Route 128 and Cambridge/Inner

   Suburbs/Greater Boston


6/13/23


100 %



428,663


N/A



N/A



365,226


$           852


275 Grove Street


Route 128/Greater Boston


6/27/23


100 %



509,702


N/A



N/A



109,349


N/A 


Other

















42,092





















602,667




Completed in 4Q23:





















640 Memorial Drive, 100 Beaver Street, and 11025

   and 11035 Roselle Street(2)


Cambridge and Inner Suburbs and

   Route 128/Greater Boston and

   Sorrento Valley/San Diego


12/20/23


100 %



361,102


N/A



N/A



312,244


$           865


380 and 420 E Street(3)


Seaport Innovation District/

Greater Boston


12/20/23


100 %



195,506


N/A



N/A



86,969


$           445


Other

















39,753





















438,966

(4)




















1,041,633




Strategic dispositions and partial interest sales





















15 Necco Street


Seaport Innovation District/

Greater Boston


4/11/23


18 %



345,996


6.6 %



5.4 %



66,108


$        1,626


9625 Towne Centre Drive


University Town Center/San Diego


6/21/23


20.1 %



163,648


4.2 %



4.5 %



32,261


$           981


421 Park Drive(5)


Fenway/Greater Boston


9/19/23


(5)



(5)


N/A



N/A



174,412


N/A 



















272,781




Total 2023 dispositions and sales of partial interests















$    1,314,414

























(1)

Represents five laboratory properties at 225, 266, and 275 Second Avenue aggregating 329,005 RSF and 780 and 790 Memorial Drive aggregating 99,658 RSF. We calculated capitalization rates of 5.0% and 5.2% (cash basis) based upon net operating income and net operating income (cash basis), respectively, for 2Q23 annualized that includes vacancy available for redevelopment. Upon completion of the sale, we recognized a gain on sales of real estate aggregating $187.2 million.

(2)

Represents four operating properties that were 46% occupied as of 3Q23 consisting of two laboratory properties at 640 Memorial Drive aggregating 242,477 RSF in Cambridgeport, MA and 100 Beaver Street aggregating 82,330 RSF in Waltham, MA, and two non-laboratory properties at 11025 and 11035 Roselle Street aggregating 36,295 RSF in our Sorrento Valley submarket. These non-core assets were not integral to our mega campus strategy and would have required significant capital to stabilize. Upon completion of the sale, we recognized a gain on sales of real estate aggregating $59.7 million.

(3)

Represents two non-laboratory properties initially acquired as industrial and self-storage space with the intention to demolish the properties upon expiration of the existing in-place leases to entitle and develop a life science campus. During 4Q23, we decided to not proceed with this project due to the change in macroeconomic environment and a lack of transit options near the properties and recognized an impairment charge of $94.8 million to reduce our investment to its current fair value less costs to sell.

(4)

Dispositions completed during the three months ended December 31, 2023 had annual net operating income of $22.7 million with a weighted-average disposition date of December 19, 2023 (weighted by net operating income for 4Q23 annualized).

(5)

Represents the disposition of 268,023 RSF in a 660,034 RSF active development project at 421 Park Drive in our Fenway submarket. The proceeds from this transaction will help fund the construction of our remaining 392,011 RSF. The project commenced vertical construction in 4Q23 and is expected to be substantially completed in 2026. The buyer will fund the remaining costs to construct its 268,023 RSF, and as such, these costs are not included in our projected construction spending. We will develop and operate the completed project and will earn development fees over the next three years.



Earnings Call Information and About the Company

December 31, 2023

We will host a conference call on Tuesday, January 30, 2024, at 3:00 p.m. Eastern Time (“ET”)/noon Pacific Time (“PT”), which is open to the general public, to discuss our financial and operating results for the fourth quarter and year ended December 31, 2023. To participate in this conference call, dial (833) 366-1125 or (412) 902-6738 shortly before 3:00 p.m. ET/noon PT and ask the operator to join the call for Alexandria Real Estate Equities, Inc. The audio webcast can be accessed at www.are.com in the “For Investors” section. A replay of the call will be available for a limited time from 5:00 p.m. ET/2:00 p.m. PT on Tuesday, January 30, 2024. The replay number is (877) 344-7529 or (412) 317-0088, and the access code is 3134066.

Additionally, a copy of this Earnings Press Release and Supplemental Information for the fourth quarter and year ended December 31, 2023 is available in the “For Investors” section of our website at www.are.com or by following this link: https://www.are.com/fs/2023q4.pdf.

For any questions, please contact Joel S. Marcus, executive chairman and founder; Peter M. Moglia, chief executive officer and chief investment officer; Marc E. Binda, chief financial officer and treasurer; Paula Schwartz, managing director of Rx Communications Group, at (917) 633-7790; or Sara M. Kabakoff, senior vice president – chief content officer.

About the Company

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a total market capitalization of $33.1 billion and an asset base in North America of 73.5 million SF as of December 31, 2023, which includes 42.0 million RSF of operating properties, 5.5 million RSF of Class A/A+ properties undergoing construction and one near-term project expected to commence construction in the next two years, 2.1 million RSF of priority anticipated development and redevelopment projects, and 23.9 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology mega campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.

***********

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our 2024 earnings per share attributable to Alexandria’s common stockholders – diluted, 2024 funds from operations per share attributable to Alexandria’s common stockholders – diluted, net operating income, and our projected sources and uses of capital. You can identify the forward-looking statements by their use of forward-looking words, such as “forecast,” “guidance,” “goals,” “projects,” “estimates,” “anticipates,” “believes,” “expects,” “intends,” “may,” “plans,” “seeks,” “should,” “targets,” or “will,” or the negative of those words or similar words. These forward-looking statements are based on our current expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, as well as a number of assumptions concerning future events. There can be no assurance that actual results will not be materially higher or lower than these expectations. These statements are subject to risks, uncertainties, assumptions, and other important factors that could cause actual results to differ materially from the results discussed in the forward-looking statements. Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, lower than expected yields, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully place into service and lease any properties undergoing development or redevelopment and our existing space held for future development or redevelopment (including new properties acquired for that purpose), our failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by tenants, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, failure to obtain LEED and other healthy building certifications and efficiencies, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”). Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are made as of the date of this Earnings Press Release and Supplemental Information, and unless otherwise stated, we assume no obligation to update this information and expressly disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

This document is not an offer to sell or a solicitation to buy securities of Alexandria Real Estate Equities, Inc. Any offers to sell or solicitations to buy our securities shall be made only by means of a prospectus approved for that purpose. Unless otherwise indicated, the “Company,” “Alexandria,” “ARE,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and our consolidated subsidiaries. Alexandria®, Lighthouse Design® logo, Building the Future of Life-Changing Innovation®, That’s What’s in Our DNA®, At the Vanguard and Heart of the Life Science Ecosystem™, Alexandria Center®, Alexandria Technology Square®, Alexandria Technology Center®, and Alexandria Innovation Center® are copyrights and trademarks of Alexandria Real Estate Equities, Inc. All other company names, trademarks, and logos referenced herein are the property of their respective owners.

Consolidated Statements of Operations

December 31, 2023

(Dollars in thousands, except per share amounts) 



Three Months Ended


Year Ended



12/31/23


9/30/23


6/30/23


3/31/23


12/31/22


12/31/23


12/31/22

Revenues:















Income from rentals


$       742,637


$      707,531


$       704,339


$       687,949


$       665,674


$    2,842,456


$    2,576,040

Other income


14,579


6,257


9,561


12,846


4,607


43,243


12,922

Total revenues


757,216


713,788


713,900


700,795


670,281


2,885,699


2,588,962
















Expenses:















Rental operations


222,726


217,687


211,834


206,933


204,352


859,180


783,153

General and administrative


59,289

(1)

45,987


45,882


48,196


42,992


199,354


177,278

Interest


31,967


11,411


17,072


13,754


17,522


74,204


94,203

Depreciation and amortization


285,246


269,370


273,555


265,302


264,480


1,093,473


1,002,146

Impairment of real estate


271,890

(2)

20,649


168,575



26,186


461,114


64,969

Loss on early extinguishment of debt








3,317

Total expenses


871,118


565,104


716,918


534,185


555,532


2,687,325


2,125,066
















Equity in earnings of unconsolidated real estate joint ventures


363


242


181


194


172


980


645

Investment income (loss)


8,654


(80,672)


(78,268)


(45,111)


(19,653)


(195,397)


(331,758)

Gain on sales of real estate


62,227



214,810




277,037


537,918

Net (loss) income


(42,658)


68,254


133,705


121,693


95,268


280,994


670,701

Net income attributable to noncontrolling interests


(45,771)


(43,985)


(43,768)


(43,831)


(40,949)


(177,355)


(149,041)

Net (loss) income attributable to Alexandria Real Estate Equities, Inc.’s

   stockholders


(88,429)


24,269


89,937


77,862


54,319


103,639


521,660

Net income attributable to unvested restricted stock awards


(3,498)


(2,414)


(2,677)


(2,606)


(2,526)


(11,195)


(8,392)

Net (loss) income attributable to Alexandria Real Estate Equities, Inc.’s

   common stockholders


$       (91,927)


$        21,855


$         87,260


$         75,256


$         51,793


$         92,444


$       513,268
















Net (loss) income per share attributable to Alexandria Real Estate Equities,

   Inc.’s common stockholders:















Basic


$           (0.54)


$            0.13


$            0.51


$            0.44


$            0.31


$            0.54


$            3.18

Diluted


$           (0.54)


$            0.13


$            0.51


$            0.44


$            0.31


$            0.54


$            3.18
















Weighted-average shares of common stock outstanding:















Basic


171,096


170,890


170,864


170,784


165,393


170,909


161,659

Diluted


171,096


170,890


170,864


170,784


165,393


170,909


161,659
















Dividends declared per share of common stock


$            1.27


$            1.24


$            1.24


$            1.21


$            1.21


$            4.96


$            4.72



(1)

Includes $18.4 million of accelerated stock compensation expense primarily related to the resignations of two executive officers, Dean A. Shigenaga from his position as President and Chief Financial Officer and John H. Cunningham from his position as Executive Vice President – Regional Market Director – New York City. Excluding this accelerated stock compensation expense, general and administrative expenses would have been $40.9 million.

(2)

Refer to “Funds from operations and funds from operations per share” of this Earnings Press Release for additional details.

 

Consolidated Balance Sheets

December 31, 2023

(In thousands)

 



12/31/23


9/30/23


6/30/23


3/31/23


12/31/22

Assets











Investments in real estate


$  31,633,511


$  31,712,731


$  31,178,054


$  30,889,395


$ 29,945,440

Investments in unconsolidated real estate joint ventures


37,780


37,695


37,801


38,355


38,435

Cash and cash equivalents


618,190


532,390


924,370


1,263,452


825,193

Restricted cash


42,581


35,321


35,920


34,932


32,782

Tenant receivables


8,211


6,897


6,951


8,197


7,614

Deferred rent


1,050,319


1,012,666


984,366


974,865


942,646

Deferred leasing costs


509,398


512,216


520,610


527,848


516,275

Investments


1,449,518


1,431,766


1,495,994


1,573,018


1,615,074

Other assets


1,421,894


1,501,611


1,475,191


1,602,403


1,599,940

Total assets


$  36,771,402


$  36,783,293


$  36,659,257


$  36,912,465


$ 35,523,399












Liabilities, Noncontrolling Interests, and Equity











Secured notes payable


$       119,662


$       109,110


$         91,939


$         73,645


$        59,045

Unsecured senior notes payable


11,096,028


11,093,725


11,091,424


11,089,124


10,100,717

Unsecured senior line of credit and commercial paper


99,952




374,536


Accounts payable, accrued expenses, and other liabilities


2,610,943


2,653,126


2,494,087


2,479,047


2,471,259

Dividends payable


221,824


214,450


214,555


209,346


209,131

Total liabilities


14,148,409


14,070,411


13,892,005


14,225,698


12,840,152












Commitments and contingencies






















Redeemable noncontrolling interests


16,480


51,658


52,628


44,862


9,612












Alexandria Real Estate Equities, Inc.’s stockholders’ equity:











Common stock


1,719


1,710


1,709


1,709


1,707

Additional paid-in capital


18,485,352


18,651,185


18,812,318


18,902,821


18,991,492

Accumulated other comprehensive loss


(15,896)


(24,984)


(16,589)


(20,536)


(20,812)

Alexandria Real Estate Equities, Inc.’s stockholders’ equity


18,471,175


18,627,911


18,797,438


18,883,994


18,972,387

Noncontrolling interests


4,135,338


4,033,313


3,917,186


3,757,911


3,701,248

Total equity


22,606,513


22,661,224


22,714,624


22,641,905


22,673,635

Total liabilities, noncontrolling interests, and equity


$  36,771,402


$  36,783,293


$  36,659,257


$  36,912,465


$ 35,523,399

 

Funds From Operations and Funds From Operations per Share

December 31, 2023

(In thousands) 


The following table presents a reconciliation of net income (loss) attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations attributable to Alexandria’s common stockholders – diluted, and funds from operations attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below:




Three Months Ended


Year Ended



12/31/23


9/30/23


6/30/23


3/31/23


12/31/22


12/31/23


12/31/22

Net (loss) income attributable to Alexandria’s common stockholders


$   (91,927)


$    21,855


$    87,260


$    75,256


$    51,793


$    92,444


$  513,268

Depreciation and amortization of real estate assets


281,939


266,440


270,026


262,124


261,185


1,080,529


988,363

Noncontrolling share of depreciation and amortization from consolidated real estate

   JVs


(30,137)


(28,814)


(28,220)


(28,178)


(29,702)


(115,349)


(107,591)

Our share of depreciation and amortization from unconsolidated real estate JVs


965


910


855


859


982


3,589


3,666

Gain on sales of real estate


(62,227)



(214,810)




(277,037)


(537,918)

Impairment of real estate – rental properties


263,982

(1)

19,844


166,602



20,899


450,428


20,899

Allocation to unvested restricted stock awards


(2,268)


(838)


(872)


(1,359)


(953)


(5,175)


(1,118)

Funds from operations attributable to Alexandria’s common stockholders –

   diluted(2)


360,327


279,397


280,841


308,702


304,204


1,229,429


879,569

Unrealized (gains) losses on non-real estate investments


(19,479)


77,202


77,897


65,855


24,117


201,475


412,193

Impairment of non-real estate investments


23,094

(3)

28,503


22,953



20,512


74,550


20,512

Impairment of real estate


7,908


805


1,973



5,287


10,686


44,070

Loss on early extinguishment of debt








3,317

Acceleration of stock compensation expense due to executive officer resignations


18,436

(4)

1,859





20,295

(4)

7,185

Allocation to unvested restricted stock awards


(472)


(1,330)


(1,285)


(867)


(482)


(4,121)


(5,137)

Funds from operations attributable to Alexandria’s common stockholders –

   diluted, as adjusted


$  389,814


$  386,436


$  382,379


$  373,690


$  353,638


$ 1,532,314


$ 1,361,709


Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in the “Definitions and reconciliations” of our Supplemental Information for additional information.



(1)

Represents impairment charges to reduce our investments in real estate assets to their respective estimated fair values less costs to sell upon their classification as held for sale, primarily consisting of non-laboratory assets that are not integral to our mega campus strategy, including (i) $94.8 million for two non-laboratory properties in our Seaport Innovation District submarket, (ii) $93.5 million for an office property in our New York City submarket, (iii) $36.1 million for a development land parcel in our Seaport Innovation District submarket, and (iv) $29.7 million for an office property in our Bothell submarket. We initially acquired these real estate assets with the intention to entitle or reposition each site as part of a life science campus, including the demolition of properties as necessary, upon expiration of the existing in-place leases, and ultimately develop or redevelop life science properties. Since acquiring these assets, the macroeconomic environment has changed and we decided not to proceed with them.

(2)

Calculated in accordance with standards established by the Nareit Board of Governors.

(3)

Primarily related to four non-real estate investments in privately held entities that do not report NAV.

(4)

Related to the resignations of two executive officers, Dean A. Shigenaga from his position as President and Chief Financial Officer and John H. Cunningham from his position as Executive Vice President – Regional Market Director – New York City.

 

Funds From Operations and Funds From Operations per Share (continued)

December 31, 2023

(In thousands, except per share amounts) 


The following table presents a reconciliation of net income (loss) per share attributable to Alexandria’s common stockholders, the most directly comparable financial measure presented in accordance with GAAP, including our share of amounts from consolidated and unconsolidated real estate joint ventures, to funds from operations per share attributable to Alexandria’s common stockholders – diluted, and funds from operations per share attributable to Alexandria’s common stockholders – diluted, as adjusted, for the periods below. Per share amounts may not add due to rounding.




Three Months Ended


Year Ended



12/31/23


9/30/23


6/30/23


3/31/23


12/31/22


12/31/23


12/31/22

Net (loss) income per share attributable to Alexandria’s common stockholders

   – diluted


$       (0.54)


$         0.13


$         0.51


$         0.44


$         0.31


$         0.54


$         3.18

Depreciation and amortization of real estate assets


1.48


1.40


1.42


1.38


1.41


5.67


5.47

Gain on sales of real estate


(0.36)



(1.26)




(1.62)


(3.33)

Impairment of real estate – rental properties


1.54


0.12


0.98



0.13


2.64


0.13

Allocation to unvested restricted stock awards


(0.01)


(0.01)


(0.01)


(0.01)


(0.01)


(0.04)


(0.01)

Funds from operations per share attributable to Alexandria’s common

   stockholders – diluted


2.11


1.64


1.64


1.81


1.84


7.19


5.44

Unrealized (gains) losses on non-real estate investments


(0.11)


0.45


0.46


0.39


0.15


1.18


2.55

Impairment of non-real estate investments


0.13


0.17


0.13



0.12


0.44


0.13

Impairment of real estate


0.05



0.02



0.03


0.06


0.27

Loss on early extinguishment of debt








0.02

Acceleration of stock compensation expense due to executive officer resignations


0.11


0.01





0.12


0.04

Allocation to unvested restricted stock awards


(0.01)


(0.01)


(0.01)


(0.01)



(0.02)


(0.03)

Funds from operations per share attributable to Alexandria’s common

   stockholders – diluted, as adjusted


$         2.28


$         2.26


$         2.24


$         2.19


$         2.14


$         8.97


$         8.42
















Weighted-average shares of common stock outstanding – diluted


171,096


170,890


170,864


170,784


165,393


170,909


161,659


Refer to “Funds from operations and funds from operations, as adjusted, attributable to Alexandria’s common stockholders” in the “Definitions and reconciliations” of our Supplemental Information for additional information.

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-reports-4q23-net-loss-per-share–diluted-of-0-54-2023-net-income-per-share–diluted-of-0-54-and-4q23-and-2023-ffo-per-share–diluted-as-adjusted-of-2-28-and-8-97–respectively-302047098.html

SOURCE Alexandria Real Estate Equities, Inc.

Featured image: Deposit Photos © Sellingpix

Disclaimer